Image Traci DeGeer BS, HT (ASCP) HTL, QIHC, Director, Advanced Staining Innovation, Leica Biosystems Traci DeGeer is the Director, Advanced Staining Innovation, Leica Biosystems. In this capacity she helps access new technologies for the Life Science research business, manages relationships with partners, works with legal partners to put agreements in place and liaises with Business Units to meet partner/customer needs as technologies are being developed. Traci holds a Bachelor of Science, in Biology, an HT, HTL, and QIHC for the anatomic pathology lab and recently graduated the HBx core program. Traci also holds a patent in small molecule detection for PDL-1 and has spoken at over one hundred state, regional and global symposia on various topics. Traci also sits on the ASCP Board of Certification (HT, HTL and QIHC Exam) and is the current Education Chair for the National Society of Histotechnology. Published Pieces by Traci DeGeer Morphology Driven High-Plex Spatial Analysis of Tissue MicroenvironmentsWebinareIn this webinar, we will show you how the integrated workflows of the Leica BOND RX and the DSP can advance your translational research. Morphology Driven High-Plex Spatial Analysis of Tissue MicroenvironmentsWebinareIn this webinar, we will show you how the integrated workflows of the Leica BOND RX and the DSP can advance your translational research. Multiplex Fluorescence Immunohistochemistry using the Ultivue InSituPlex Platform on the Leica Biosystems BOND RXWebinareMultiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the analysis of target protein expression in subsets of specific cells within the context of histopathological features of disease. Multiplex Fluorescence Immunohistochemistry using the Ultivue InSituPlex Platform on the Leica Biosystems BOND RXWebinareMultiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the analysis of target protein expression in subsets of specific cells within the context of histopathological features of disease. Automated Multiplex ImmunofluorescenceWebinarsIn this webinar, we will discuss how Akoya Biosciences Phenoptics assays support quantitative mIF to overcome the limitations imposed by conventional IHC methodologies. We will also discuss how our Opal assay kits and reagents can be integrated with the Leica Automated Multiplex ImmunofluorescenceWebinarsIn this webinar, we will discuss how Akoya Biosciences Phenoptics assays support quantitative mIF to overcome the limitations imposed by conventional IHC methodologies. We will also discuss how our Opal assay kits and reagents can be integrated with the Leica
